Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score -3.66
- Piotroski Score 2.00
- Grade Market Outperform
- Symbol (HOOK)
- Company HOOKIPA Pharma Inc.
- Price $3.84
- Changes Percentage (2.16%)
- Change $0.08
- Day Low $3.78
- Day High $3.86
- Year High $11.30
HOOKIPA Pharma Inc., a clinical stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase II clinical trial in patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in Phase I/II clinical trial for the treatment of human papillomavirus 16-positive cancers. The company's preclinical stage products include HB-300 program for prostate cancer; and HB-700 for targeting mutated KRAS in pancreatic, colorectal, and lung cancer. HOOKIPA Pharma Inc. has a collaboration with Gilead Sciences, Inc. to collaborate on preclinical research programs to evaluate potential vaccine products using or incorporating its replicating and non-replicating technology platforms for the treatment, cure, diagnosis, or prevention of Hepatitis B Virus. The company was incorporated in 2011 and is headquartered in New York, New York.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 11/07/2024
- Fiscal Year End N/A
- Average Stock Price Target $3.00
- High Stock Price Target $3.00
- Low Stock Price Target $3.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$0.48
- Trailing P/E Ratio -1.71
- Forward P/E Ratio -1.71
- P/E Growth -1.71
- Net Income $-81,580,000
Income Statement
Quarterly
Annual
Latest News of HOOK
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Exclusive | Open-air sex market is exploding in Brooklyn as hookers openly sell...
East New York's Penn Track is plagued by an increase in open-air prostitution, causing concern for residents and officials. Despite promises from law enforcement, the issue persists with allegations o...
By New York Post | 2 days ago -
How Did Anthony Richardson Get A Quicker Hook Than Bryce Young?
The NFL is facing a quarterback development challenge, with top draft picks losing starting roles early in the season. Bryce Young and Anthony Richardson have faced setbacks, highlighting the risks an...
By Forbes | 4 days ago -
'DWTS' pro Emma Slater is 'hooking up' with Alan Bersten after Sasha...
"Dancing with the Stars" pros Emma Slater and Alan Bersten are reportedly in a relationship, with rumors circulating for years. Slater, previously married to Sasha Farber, and Bersten are keeping thei...
By New York Post | 5 days ago
